Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (NASDAQ:EXAI) Finances February 26, 2024 [ad_1] adventtrThe Exscientia Experiment: When AI Meets Pharma Realities Exscientia’s (NASDAQ:EXAI) inventory is off 22% since my “Purchase” advice in…
